<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="18421">Superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> (<z:chebi fb="38" ids="18421,29356">O2-</z:chebi>) production and expression of <z:chebi fb="0" ids="38551">cytochrome b</z:chebi> 558 by neutrophils were determined in 20 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The reduction of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production was noted in eight of the 20 patients and an increase was noted in four patients when neutrophils were stimulated by n-formyl-<z:chebi fb="0" ids="32648">methionyl</z:chebi>-<z:chebi fb="0" ids="32630">leucyl</z:chebi>-phenylalanine (<z:chebi fb="0" ids="53490">FMLP</z:chebi>), while a low level of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production was found in 11 and an increase in six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients when they were stimulated by <z:chebi fb="0" ids="8116">phorbol</z:chebi> <z:chebi fb="0" ids="30807">myristate</z:chebi> <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Among them, seven patients showed a decrease and four an increase in <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production on stimulation with either <z:chebi fb="0" ids="53490">FMLP</z:chebi> or <z:chebi fb="1" ids="53780">PMA</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Expression of <z:chebi fb="0" ids="38551">cytochrome b</z:chebi> 558 was found to be at low levels in patients who had neutrophils showing decreased <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production when stimulated with <z:chebi fb="0" ids="53490">FMLP</z:chebi>, indicating that decreased expression of <z:chebi fb="0" ids="38551">cytochrome b</z:chebi> 558 might contribute to the impairment of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production in some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, no significant differences in <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production were noted among subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; however, the patients who had received <z:chebi fb="2" ids="8378">prednisolone</z:chebi> showed lower levels of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production than those who had not received <z:chebi fb="2" ids="8378">prednisolone</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Patients manifesting episodes of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> had reduced levels of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production compared with those without <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, the fact that one patient who exhibited a marked reduction in neutrophil counts together with reduced <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production died of fatal <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, suggests that the determination of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> production, in combination with hematological features, may be of some help in predicting severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
</text></document>